Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus

Springer Semin Immunopathol. 1994;16(2-3):327-36. doi: 10.1007/BF00197526.

Authors

R N Maini¹, M J Elliott, P J Charles, M Feldmann

Affiliation

¹ Kennedy Institute of Rheumatology, London, UK.

PMID: 7716713
DOI: 10.1007/BF00197526

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Arthritis, Rheumatoid / drug therapy
Arthritis, Rheumatoid / immunology*
Clinical Trials as Topic
Female
Humans
Interleukin-10 / adverse effects
Interleukin-10 / immunology*
Interleukin-10 / therapeutic use
Lupus Erythematosus, Systemic / drug therapy
Lupus Erythematosus, Systemic / immunology*
Middle Aged
Tumor Necrosis Factor-alpha / adverse effects
Tumor Necrosis Factor-alpha / immunology*
Tumor Necrosis Factor-alpha / therapeutic use

Substances

Tumor Necrosis Factor-alpha
Interleukin-10